ChristyLynnYoungMDboard certified

PubMed

• A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
  Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung H, Krantz M, Ferenczi L, Verco T> ;Neurology. 2011-10-18
• Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently.
  Young C, Miller E, Nicklous DM, Hoffman JR> ;Restor. Neurol. Neurosci.. 2001-01-01
• Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group.
  Murphy N, Confavreux C, Haas J, König N, Roullet E, Sailer M, Swash M, Young C, Mérot JL> ;J. Neurol. Neurosurg. Psychiatr.. 1998-10-01
• Strokes in children: a medical center-based study.
  Wang LH, Young C, Lin HC, Wang PJ, Lee WT, Shen YZ> ;Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998-01-01
• Questionable competency of a surrogate decision maker under a durable power of attorney.
  McCrary SV, Allen WL, Young CL> ;J Clin Ethics. 1993-01-01
• Join now to see all